Back
General Enterprise Ventures Vs. Dyne Therapeutics Industry Stock Comparison
Buy
63
GEVI
General Enterprise Ventures
Last Price:
0.7000
Seasonality Move:
225.84%
Sell
31
DYN
Dyne Therapeutics
Last Price:
33.84
Seasonality Move:
5.51%
Buy
63
General Enterprise Ventures (GEVI)
is a Buy
Is General Enterprise Ventures a Buy, Sell or Hold?
- The current General Enterprise Ventures [GEVI] share price is $0.6998. The Score for GEVI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- GEVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $33.83. The Score for DYN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GEVI Stock Price Chart
What is General Enterprise Ventures's stock price today?
-
The General Enterprise Ventures share price today is $0.6998
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GEVI is experiencing selling pressure, which indicates risk of future bearish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $33.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
GEVI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 42.69 | Sell |
Chaikin Money Flow: | -2100 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6927 - 0.8927) | Sell |
Bollinger Bands (100): | (0.6018 - 0.7818) | Buy |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.64 | Sell |
Relative Strength Index (14 RSI): | 40.26 | Sell |
Chaikin Money Flow: | -399891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.67 - 41.65) | Sell |
Bollinger Bands (100): | (30.76 - 42.62) | Sell |
GEVI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.81 | Sell |
20-day SMA: | 0.83 | Sell |
50-day SMA: | 0.7 | Buy |
200-day SMA: | 0.74 | Sell |
8-day EMA: | 0.79 | Sell |
20-day EMA: | 0.79 | Sell |
50-day EMA: | 0.74 | Sell |
200-day EMA: | 0.7 | Buy |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.84 | Sell |
20-day SMA: | 34.54 | Sell |
50-day SMA: | 40.17 | Sell |
200-day SMA: | 29.41 | Buy |
8-day EMA: | 34.53 | Sell |
20-day EMA: | 35.81 | Sell |
50-day EMA: | 37.51 | Sell |
200-day EMA: | 30.51 | Buy |
General Enterprise Ventures Earnings Growth & GEVI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.82 per share, and a decrease next year of $0.01 per share.
General Enterprise Ventures Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |